Literature DB >> 29472234

Hypoxia Triggers SENP1 (Sentrin-Specific Protease 1) Modulation of KLF15 (Kruppel-Like Factor 15) and Transcriptional Regulation of Arg2 (Arginase 2) in Pulmonary Endothelium.

Deepesh Pandey1, Yohei Nomura2, Max C Rossberg2, Daijiro Hori2, Anil Bhatta2, Gizem Keceli2, Thorsten Leucker2, Lakshmi Santhanam2, Larissa A Shimoda2, Dan Berkowitz2, Lewis Romer2.   

Abstract

OBJECTIVE: KLF15 (Kruppel-like factor 15) has recently been shown to suppress activation of proinflammatory processes that contribute to atherogenesis in vascular smooth muscle, however, the role of KLF15 in vascular endothelial function is unknown. Arginase mediates inflammatory vasculopathy and vascular injury in pulmonary hypertension. Here, we tested the hypothesis that KLF15 is a critical regulator of hypoxia-induced Arg2 (arginase 2) transcription in human pulmonary microvascular endothelial cells (HPMEC). APPROACH AND
RESULTS: Quiescent HPMEC express ample amounts of full-length KLF15. HPMECs exposed to 24 hours of hypoxia exhibited a marked decrease in KLF15 protein levels and a reciprocal increase in Arg2 protein and mRNA. Chromatin immunoprecipitation indicated direct binding of KLF15 to the Arg2 promoter, which was relieved with HPMEC exposure to hypoxia. Furthermore, overexpression of KLF15 in HPMEC reversed hypoxia-induced augmentation of Arg2 abundance and arginase activity and rescued nitric oxide (NO) production. Ectopic KLF15 also reversed hypoxia-induced endothelium-mediated vasodilatation in isolated rat pulmonary artery rings. Mechanisms by which hypoxia regulates KLF15 abundance, stability, and compartmentalization to the nucleus in HPMEC were then investigated. Hypoxia triggered deSUMOylation of KLF15 by SENP1 (sentrin-specific protease 1), and translocation of KLF15 from nucleus to cytoplasm.
CONCLUSIONS: KLF15 is a critical regulator of pulmonary endothelial homeostasis via repression of endothelial Arg2 expression. KLF15 abundance and nuclear compartmentalization are regulated by SUMOylation/deSUMOylation-a hypoxia-sensitive process that is controlled by SENP1. Strategies including overexpression of KLF15 or inhibition of SENP1 may represent novel therapeutic targets for pulmonary hypertension.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  arginase; cytoplasm; endothelium; hypoxia; pulmonary artery

Mesh:

Substances:

Year:  2018        PMID: 29472234      PMCID: PMC6738933          DOI: 10.1161/ATVBAHA.117.310660

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  60 in total

Review 1.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

2.  Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1.

Authors:  Yasuhito Terui; Natalie Saad; Shidong Jia; Frank McKeon; Junying Yuan
Journal:  J Biol Chem       Date:  2004-04-26       Impact factor: 5.157

3.  Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha.

Authors:  A Y Yu; L A Shimoda; N V Iyer; D L Huso; X Sun; R McWilliams; T Beaty; J S Sham; C M Wiener; J T Sylvester; G L Semenza
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  Nitric oxide synthase expression in lungs of pulmonary hypertensive patients with heart disease.

Authors:  H Komai; Y Naito; Y Aimi; H Kimura
Journal:  Cardiovasc Pathol       Date:  2001 Jan-Feb       Impact factor: 2.185

5.  Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels.

Authors:  Dan E Berkowitz; Ron White; Dechun Li; Khalid M Minhas; Amy Cernetich; Soonyul Kim; Sean Burke; Artin A Shoukas; Daniel Nyhan; Hunter C Champion; Joshua M Hare
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

6.  Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia.

Authors:  Koen Brusselmans; Veerle Compernolle; Marc Tjwa; Michael S Wiesener; Patrick H Maxwell; Désiré Collen; Peter Carmeliet
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Sumoylation increases HIF-1alpha stability and its transcriptional activity.

Authors:  Seong-Hui Bae; Joo-Won Jeong; Jeong Ae Park; Se-Hee Kim; Moon-Kyoung Bae; Soo-Joon Choi; Kyu-Won Kim
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

8.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.

Authors:  Weiling Xu; F Takao Kaneko; Shuo Zheng; Suzy A A Comhair; Allison J Janocha; Tannishia Goggans; Frederik B J M Thunnissen; Carol Farver; Stanley L Hazen; Constance Jennings; Raed A Dweik; Alejandro C Arroliga; Serpil C Erzurum
Journal:  FASEB J       Date:  2004-09-13       Impact factor: 5.191

9.  Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension.

Authors:  Takahisa Murata; Koichi Sato; Masatoshi Hori; Hiroshi Ozaki; Hideaki Karaki
Journal:  J Biol Chem       Date:  2002-08-15       Impact factor: 5.157

10.  SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1.

Authors:  Sara Salinas; Anne Briançon-Marjollet; Guillaume Bossis; Marie-Aude Lopez; Marc Piechaczyk; Isabelle Jariel-Encontre; Anne Debant; Robert A Hipskind
Journal:  J Cell Biol       Date:  2004-06-21       Impact factor: 10.539

View more
  7 in total

Review 1.  Vascular Endothelial Cells and Innate Immunity.

Authors:  Ying Shao; Jason Saredy; William Y Yang; Yu Sun; Yifan Lu; Fatma Saaoud; Charles Drummer; Candice Johnson; Keman Xu; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-27       Impact factor: 8.311

Review 2.  The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.

Authors:  Jana Krystofova; Praneeti Pathipati; Jeffrey Russ; Ann Sheldon; Donna Ferriero
Journal:  Dev Neurosci       Date:  2019-04-17       Impact factor: 2.984

Review 3.  Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-23       Impact factor: 8.311

4.  miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension.

Authors:  Jing Jiang; Yimeng Xia; Yi Liang; Meiling Yang; Wen Zeng; Xiaocong Zeng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-20

Review 5.  Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression.

Authors:  Shunqin Zhu; Hongyu Gu; Cheng Peng; Fanwei Xia; Huan Cao; Hongjuan Cui
Journal:  Front Cell Dev Biol       Date:  2022-03-21

6.  Role of Arginase-II in Podocyte Injury under Hypoxic Conditions.

Authors:  Zhilong Ren; Duilio Michele Potenza; Yiqiong Ma; Guillaume Ajalbert; David Hoogewijs; Xiu-Fen Ming; Zhihong Yang
Journal:  Biomolecules       Date:  2022-08-31

7.  SENP1 has an important role in lung development and influences the differentiation of alveolar type 2 cells.

Authors:  Xue-Qing Wan; Jia-Yu Cai; Yue Zhu; Qiu-Xia Wang; Hai-Tao Zhu; Hui-Min Ju; Hong-Yan Lu
Journal:  Int J Mol Med       Date:  2018-10-29       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.